Infections of intravascular perfusion sets;Infections sur dispositifs intravasculaires de perfusion

Revue du Praticien

Volumn 53, Issue 19, 2003, Pages 2119-2127

  Blot, François ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; AMIKACIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAM ANTIBIOTIC; GENTAMICIN; METICILLIN;

ANALYTIC METHOD; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANCER; CANDIDA; CATHETER INFECTION; CAUSE OF DEATH; CELLULITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY DIAGNOSIS; ENDOCARDITIS; FUNGUS CULTURE; HUMAN; LEUKOCYTE CYTOSPIN TEST; MORBIDITY; NONHUMAN; PREVENTIVE MEDICINE; PSEUDOMONAS; QUANTITATIVE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; STAPHYLOCOCCUS AUREUS; SYSTEMIC DISEASE; THROMBOPHLEBITIS; TIME; TISSUE DISTRIBUTION; VASCULAR ACCESS;

BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; INFECTION; RISK FACTORS;

EID: 0345871366     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001; 22: 222-42.
2. Soufir L, Timsit JF, Mahe C et al. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20: 396-401.
3. Richet H, Hubert B, Nitenberg G et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28: 2520-5.
4. Jernigan J, Farr B. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 1993; 119: 304-11.
5. Raad I, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197-210.
6. Abbas J, Bodey GP, Hanna HA et al. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160: 2659-64.
7. Joly C, Astagneau P. Les infections nosocomiales: les infections sur cathéters de longue durée (schémas des dispositifs, techniques de pose, gestion, surveillance). Med Ther 2000; 6 (HS1): 68-74.
8. Nucci M, Colombo AL, Silveira F et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998; 19: 846-50.
9. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001; 163: 1584-90.
10. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282: 5545-60.
11. Pittet D, Tarara D, Wenzel RP. Nososcomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601.
12. Raad I, Costerton W, Sabharwal U et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-7.
13. Elliott TS, Moss HA, Tebbs SE et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997; 16: 210-3.
14. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol 1996; 17: 438-73.
15. Raad II, Hohn DC, Gilbreath BJ et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-8.
16. Merrer J, De Jonghe B, Golliot F et al, for the French Catheter Study Group in Intensive Care. Complications of femoral and subclavian venous catheterization in critically ill patients. A randomized controlled trial. JAMA 2001; 286: 700-7.
17. Timsit JF, Sebille V, Farkas JC et al. Effect of subcutaneous tunnelling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276: 1416-20.
18. Timsit JF, Bruneel F, Cheval C et al. Use of tunnelled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 1999; 130: 729-35.
19. Randolph AG, Cook DJ, Gonzales CA et al. Tunnelling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998; 26: 1452-7.
20. Reynolds MG, Tebbs SE, Elliott TS. Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis? Intens Crit Care Nurs 1997; 13: 26-9.
21. Nikoletti S, Leslie G, Gandossi S et al. A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 1999; 27: 488-96.
22. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.
23. Mimoz O, Pieroni L, Lawrence C et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24: 1818-23.
24. Keohane PP, Jones BJ, Attrill H et al. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet 1983; 2: 1388-90.
25. Bcudier B, Lethiec J, Angevin E et al. Totally implantable catheters to reduce catheter-related infections in patients receiving interleukin-2: a 2-year experience. Support Care Cancer 1995; 3: 297-300.
26. Maki DG, Stolz SM, Wheeler S et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257-66.
27. Veenstra DL, Saint S, Saha S et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 1999; 281: 261-7.
28. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1-8.
29. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2000; 21: 375-80.
30. Timsit JF, Farkas JC, Boyer JM et al. Central vein catheter-related thrombosis in intensive care patients. Incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114: 207-13.
31. Boraks P, Seale J, Price J et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483-6.
32. Randolph AG, Cook DJ, Gonzales CA et al. Benefit of heparin in central venous and pulmonary artery catheters. A meta-analysis of randomized controlled trials. Chest 1998; 113: 165-71.
33. Eggimann P, Harbarth S, Constantin MN et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-8.
34. Civetta JM, Hudson-Civetta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 1996; 24: 1660-5.
35. Ryan JA, Abel RM, Abbott WM et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974; 290: 757-61.
36. Siegman-Igra Y, Anglim AM, Shapiro DE et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-36.
37. Maki DG, Weise CE, Sarafin HW. A semi-quantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-9.
38. Brun-Buisson C, Abrouk F, Legrand P et al. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-7.
39. Sherertz RJ, Raad II, Belani A et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76-82.
40. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-8.
41. Douard MC, Arlet G, Longuet P et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999; 29: 1197-202.
42. Bjornson HS, Colley R, Bower RH et al. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982; 92: 720-5.
43. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995; 20: 593-7,
44. Liñares J, Sitges-Serra A, Garau J et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985; 21: 357-60.
45. Andremont A, Paulet R, Nitenberg G et al. Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients. J Clin Microbiol 1988; 26: 2297-9.
46. Snydman DR, Murray SA, Kornfeld SJ et al. Total parenteral nutrition-related infections. Prospective epidemiologic study using semi-quantitative methods. Am J Med 1982; 73: 695-9.
47. Wing EJ, Norden CW, Shadduck RK et al. Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med 1979; 139: 482-3.
48. Capdevila JA, Planes AM, Palomar M et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 1992; 11: 403-7.
49. Douard MC, Arlet G, Leverger G et al. Ouantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 1991; 17: 30-5.
50. Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of central-venous versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36: 105-9.
51. Blot F, Nitenberg G, Chachaty E et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of central vs. peripheral blood cultures. Lancet 1999; 354: 1071-7.
52. Malgrange VB, Escande MC, Theobald S. Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J Clin Microbiol 2001; 39: 274-8.
53. Kite P, Dobbins BM, Wilcox MH et al. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999; 354: 1504-7.
54. Farr BM. Accuracy and cost-effectiveness of new tests for diagnosis of catheter-related bloodstream infections. Lancet 1999; 35: 1487-8.
55. Seifert H, Cornely O, Seggewiss K et al. Bloodstream infection in neutropenic cancer patients related to short-term non tunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 2003; 41: 118-23.
56. Elliott TSJ, Tebbs SE, Moss HA et al. A novel serological test for the diagnosis of central venous catheter-associated sepsis. J Hosp Infection 2000; 40: 262-6.
57. Blot F, Brun-Buisson C. Current approaches to the diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 1999; 5: 341-9.
58. Xlle Conférence de Consensus en réanimation et médecine d'urgence. Infections liées aux cathéters veineux centraux en réanimation. Rean Urg 1994; 3: 321-30.
59. Longuet P, Douard MC, Arlet G et al. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 2001; 32: 1776-83.
60. Capdevila JA, Segarra A, Planes AM et al. Long-term follow-up of patients with catheter-related bacteremia treated without catheter removal. Clin Microbiol Infect 1998; 4: 472-6.